SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jay silberman who wrote (2304)10/14/1997 9:52:00 AM
From: JOHN W.   of 6136
 
As a taxpayer, these patients that get turned away from the drugs will eventually get very sick and end up costing the taxpayers much more. Penny wise and pound foolish. I thought this issue was resolved by the govt. This is outrageous. To offer hope and dangle it in front of them. AGPH has a very aggressive camposionate use policy, why should the co and the shareholders pick up the load for the society and govt! Regardlees of your view of AGPH, these people are just that, people.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News